- Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
-
Kamat N, Vuyyuru SK, Kedia S, Sahu P, Kante B, Kumar P, Ranjan MK, Singh MK, Kumar S, Sachdev V, Makharia G, Ahuja V
- KMID: 2529573
- Intest Res.
- 2022 Apr;20(2):269-273.
- doi: 10.5217/ir.2021.00064
-
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
-
Sachdeva K, Kumar P, Kante B, Vuyyuru SK, Mohta S, Ranjan MK, Singh MK, Verma M, Makharia G, Kedia S, Ahuja V
- KMID: 2541895
- Intest Res.
- 2023 Apr;21(2):226-234.
- doi: 10.5217/ir.2022.00010
Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD,... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
-
Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V
- KMID: 2547196
- Intest Res.
- 2023 Oct;21(4):460-470.
- doi: 10.5217/ir.2022.00128
Background/Aims: Evidence on predictors of primary nonresponse (PNR), and secondary loss of response (SLR) to anti-tumor necrosis factor (anti-TNF) agents in inflammatory bowel disease is scarce from Asia. We evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of thiopurines in inflammatory bowel disease: an update
-
Singh A, Mahajan R, Kedia S, Dutta AK, Anand A, Bernstein CN, Desai D, Pai CG, Makharia G, Tevethia HV, Mak JW, Kaur K, Peddi K, Ranjan MK, Arkkila P, Kochhar R, Banerjee R, Sinha SK, Ng SC, Hanauer S, Verma S, Dutta U, Midha V, Mehta V, Ahuja V, Sood A
- KMID: 2525069
- Intest Res.
- 2022 Jan;20(1):11-30.
- doi: 10.5217/ir.2020.00155
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
